Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases

In the last decade, scientists have made great strides in uncovering details of the underlying causes of neurodegenerative diseases. It is only a matter of time that treatment and prevention…

Continue Reading Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases
Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!
source: pixabay.com

Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!

Severe Combined Immunodeficiency Severe combined immunodeficiency (SCID) is a group of diseases caused by mutations that affect how the immune system works to fight infections. These anomalies are usually passed…

Continue Reading Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!
A Molecular Signature on Stressed Liver Cells Provides PSC Patients With A New Clue to Their Condition
source: pixabay.com

A Molecular Signature on Stressed Liver Cells Provides PSC Patients With A New Clue to Their Condition

The rare liver disease primary sclerosing cholangitis (PSC) may impact just .01% of people, but the extremely pernicious disorder's attacks on the liver mean bearers of the disorder account for…

Continue Reading A Molecular Signature on Stressed Liver Cells Provides PSC Patients With A New Clue to Their Condition
The FDA Approves An Expanded Chemotherapy Treatment For Acute Myeloid Leukemia to Include Children
source: pixabay.com

The FDA Approves An Expanded Chemotherapy Treatment For Acute Myeloid Leukemia to Include Children

  Cancer Network recently reported that Jazz Pharmaceuticals’ Vyxeos was approved by the FDA to treat therapy-related pediatric patients one year or older who were newly diagnosed with acute myeloid…

Continue Reading The FDA Approves An Expanded Chemotherapy Treatment For Acute Myeloid Leukemia to Include Children
Businesses Can Support Employees’ Participation in Clinical Trials and Change the Future of Research
source: pixabay.com

Businesses Can Support Employees’ Participation in Clinical Trials and Change the Future of Research

Financial Burdens in Rare Disease In 2019, 20% of all adults in the United States have reported that they had large medical bills that were unexpected. 18% currently had medical…

Continue Reading Businesses Can Support Employees’ Participation in Clinical Trials and Change the Future of Research